Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Sell
2,150
-500
-19% -$158K 0.05% 127
2026
Q1
$871K Hold
2,650
0.12% 110
2025
Q4
$931K Sell
2,650
-400
-13% -$146K 0.13% 101
2025
Q3
$1.13M Sell
3,050
-1,100
-27% -$425K 0.16% 89
2025
Q2
$1.64M Hold
4,150
0.26% 75
2025
Q1
$1.54M Hold
4,150
0.29% 73
2024
Q4
$1.49M Buy
+4,150
New +$1.54M 0.26% 74

Other funds holding SYK

Sava Infond's SYK Position: Q2 2026 in Review

Sava Infond reduced its Stryker (SYK) stake by 19% in Q2 2026, selling an estimated $158K and leaving 2,150 shares worth $677K. The position accounts for 0.05% of the portfolio, ranked #127.

Sava Infond first reported a position in SYK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.64M in Q2 2025. 857 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Sava Infond held 2,150 shares of Stryker worth $677K as of Q2 2026.
  • Sava Infond sold 500 Stryker shares in Q2 2026, an estimated $158K.
  • Stryker made up 0.05% of Sava Infond's portfolio in Q2 2026, its #127 holding.
  • Sava Infond first reported a position in Stryker in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Stryker position peaked at $1.64M in Q2 2025.
  • 857 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.